De Weerdt Elfi, Simoens Steven, Casteels Minne, Huys Isabelle
Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven Leuven, Belgium.
Front Pharmacol. 2015 Oct 30;6:253. doi: 10.3389/fphar.2015.00253. eCollection 2015.
Drug shortages are currently on the rise. In-depth investigation of the problem is necessary, however, a variety of definitions for 'drug shortages' are formulated in legislations, by different organizations, authorities, and other initiatives. For international comparison, the underlying definition for drug shortages is important to allow appropriate interpretation of national databases and the results of scientific studies. The objective is to identify the different elements which should be considered in a uniform definition for drug shortages in the European Union (EU) and to detect the different conditions for reporting drug shortages.
Definitions of drug shortages were searched in the scientific databases as well as in the gray literature. Similar topics were identified and organizations were contacted to formulate the reasoning underlying the definitions.
Over 20 different definitions for drug shortages were identified. A distinction is made between general definitions of drug shortages and definitions used for the reporting of drug shortages. Differences and similarities are observed in the elements within the definitions, e.g., when does a supply problem become a drug shortage, permanent and/or temporally shortages, the typology and time frame of a drug shortage. The moment a supply problem is considered as a shortage, can be defined at four levels: (i) demand side, (ii) supply side, (iii) delivery of a drug, and (iv) availability of a drug. Permanent discontinuations of drugs are not always covered in definitions for drug shortages. Some definitions only consider those drugs used for the treatment of serious diseases or drugs for which no alternative is available. Different time frames were observed, varying between 1 day and 20 days.
Obtaining a uniform definition for drug shortages is important as well as identifying which conditions are preferable to report drug shortages in order to facilitate international benchmarking. This paper can be used as a guidance to point out all the different elements which should be considered to formulate a uniform definition to be applied in the EU.
目前药品短缺情况呈上升趋势。有必要对该问题进行深入调查,然而,立法机构、不同组织、当局及其他倡议对“药品短缺”制定了多种定义。为进行国际比较,药品短缺的基本定义对于正确解读国家数据库及科学研究结果至关重要。目的是确定在欧盟(EU)药品短缺统一定义中应考虑的不同要素,并查明报告药品短缺的不同条件。
在科学数据库以及灰色文献中搜索药品短缺的定义。确定类似主题,并与各组织联系以阐述定义背后的推理。
确定了20多种不同的药品短缺定义。药品短缺的一般定义与用于报告药品短缺的定义有所不同。在定义要素中观察到了差异和相似之处,例如,供应问题何时成为药品短缺、永久性和/或临时性短缺、药品短缺的类型和时间框架。供应问题被视为短缺的时刻可在四个层面定义:(i)需求方;(ii)供应方;(iii)药品交付;(iv)药品可获得性。药品的永久性停产在药品短缺定义中并非总是涵盖在内。一些定义仅考虑用于治疗严重疾病的药品或没有替代药品的药品。观察到不同的时间框架,从1天到20天不等。
获得药品短缺的统一定义以及确定报告药品短缺的最佳条件以促进国际基准比较非常重要。本文可作为指南,指出制定适用于欧盟的统一定义时应考虑的所有不同要素。